Navigation Links
Two In One Drug For Smokers And Drinkers

It could be described as the stone that kills two vices. United States FDA-approved smoking cessation drug varenicline , is posing to be handed out to alcoholics as well .

The Pfizer manufactured drug, sold under the name Chantix, which has been used quite successfully by smokers , was tested to reveal the same effects in alcoholics too, of the furry kind, lab rats.

Says Selena Bartlett, a University of California, San Francisco neuroscientist who led the study: "The biggest thrill is that this drug, which has already proved safe for people trying to stop smoking, is now a potential drug to fight alcohol dependence."

In the study, the researchers trained rats to drink alcohol and measured the effect of varenicline once the animals became the lab equivalent of heavy drinkers. They found the drug curbed their drinking. Even when stopped, the rats resumed drinking but did not binge.

The study is outlined in the journal Proceedings of the National Academy of Sciences.

The drug varenicline is said to work by latching onto the same receptors in the brain that nicotine binds to, when inhaled in cigarette smoke, an action that leads to the release of dopamine in the brain's pleasure centers. Taking the drug blocks any inhaled nicotine from enhancing that effect.

Varenicline has been available as a smoking cessation aid for nearly a year in the U.S. and the European Union, and as well as being safe it does not suppress the appetite and is not metabolized in the liver. According to Bartlett this is a major advantage because long-term drinkers often have liver damage. In addition, the drug has the potential to be considered as a treatment for addictions such as gambling and painkillers.

The University of California researchers, together with the U.S. National Institute on Alcohol Abuse and Alcoholism, are planning the first studies in humans of the drug's effectiveness in curbing alcohol cr avings and dependence, according to Bartlett.

At the same time, several experts not involved in the study warn that there is no such thing as a magic cure-all for addiction and that varenicline and such drugs may find more immediate use in treating diseases like Alzheimer's and Parkinson's.


Related medicine news :

1. Smokers children likely to develop caries
2. Smokers more prone to depression
3. Female Smokers More Prone To Lung Cancer
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women Smokers More Prone To Lung Cancer
6. Creating A Greater Awareness Among Smokers
7. Smokers may differ in their cravings for smoking
8. Trained Counselors Counseling Pregnant Smokers To Quit May Not Work
9. Smokers Avoid Dental Care More Than Others
10. Smokers Face The Risk Of Becoming Blind In Later Life
11. New Vaccination For Smokers To Quit Smoking
Post Your Comments:

(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... at the 7th Annual 2015 Golden Bridge Business Awards under the New Products ... a zero capex web based sample management software that helps labs ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the ... North America Annual Meeting from November 29 to December 4, 2015. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... Francisco, CA (PRWEB) , ... December 01, 2015 ... ... Behavioral Health Center of Excellence (BHCOE) today announced that the organization has awarded ... in San Francisco, with a Distinguished Award. The award celebrates exceptional special needs ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Building on ... Johnson & Johnson (NYSE: JNJ ) today ... Pharmaceutical Companies to significantly reduce the burden of ... up 74 percent of new HIV infections among ... World AIDS Day, these new initiatives include collaborations ...
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... today that the company will present at the LD Micro ... the Luxe Sunset Boulevard Hotel in Los Angeles, ... Therapeutics, will present on Thursday, December 3, at 9:00 am ... Please register at least 10 minutes prior to the start ...
Breaking Medicine Technology: